Table 4. Estimated relative prescription rate (Rpr) of the studied drug for participating physicians versus controls.

Time frame	Number of packages		DDD*
	Rpr** (95% CI)	p-Value	Rpr (95% CI)	p-Value
t0	1.04 (1.03–1.05)	<0.001	1.04 (1.03–1.04)	<0.001
t1	1.08 (1.07–1.10)	<0.001	1.07 (1.06–1.09)	<0.001
t2	1.07 (1.05–1.09)	<0.001	1.06 (1.04–1.08)	<0.001

Model for t0 adjusted for overall prescription rate; models for t1 and t2 adjusted for overall prescription rate and prescription rate of studied drug at t0.

*Defined daily dose (DDD) of the drug studied in the non-interventional post-marketing study.

**Relative rate; n = 2,354 groups.